Evidence map›Paper›PMID 35342648›Full record

ArticleInternational journal of nephrology2022

Amelioration of Nephrotoxicity in Mice Induced by Antituberculosis Drugs Using

Abebe Dukessa Dubiwak, Urge Gerema, Daba Abdisa, Ebsa Tofik, Wondu Reta

Open access · goldAbstract read
In one paragraph

Article in International journal of nephrology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Abebe Dukessa DubiwakDivision of Medical Biochemistry, Department of Biomedical Sciences, Faculty of Medical Sciences, Institute of Health Sciences, Jimma University, Jimma, Ethiopia.ORCID https://orcid.org/0000-0002-3260-8382
Urge GeremaDivision of Clinical Anatomy, Department of Biomedical Sciences, Faculty of Medical Sciences, Institute of Health Sciences, Jimma University, Jimma, Ethiopia.ORCID https://orcid.org/0000-0001-5286-5100
Daba AbdisaDivision of Clinical Anatomy, Department of Biomedical Sciences, Faculty of Medical Sciences, Institute of Health Sciences, Jimma University, Jimma, Ethiopia.ORCID https://orcid.org/0000-0002-2979-7450
Ebsa TofikDepartment of Biology, College of Natural and Computational Sciences, Mettu University, Metu, Ethiopia.ORCID https://orcid.org/0000-0001-9399-059X
Wondu RetaDivision of Medical Physiology, Department of Biomedical Sciences, Faculty of Medical Sciences, Institute of Health Sciences, Jimma University, Jimma, Ethiopia.ORCID https://orcid.org/0000-0002-3888-0774
Jimma University · ETEthiopian Civil Service University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Antituberculosis drugs are antimicrobial agents important for treating a communicable disease called tuberculosis. Despite their importance, antituberculosis drugs such as isoniazid and rifampicin have severe adverse effects like nephrotoxicity with acute renal failures. Methods: The present study was conducted on thirty Swiss albino mice randomly allocated into five groups. Group-I (only distilled water), Group-II (only isoniazid 75 mg/kg and rifampicin150 mg/kg), Group-III (isoniazid and rifampicin along with 200 mg/kg EVCE), Group-IV (isoniazid and rifampicin along with 400 mg/kg EVCE), and Group-V (isoniazid and rifampicin along with silymarin) were treated for thirty days. At the end of the study, the experimental animals were sacrificed after being injected with anesthetic drug, blood was drawn for a kidney function test, and the kidney was also taken from each experimental animal for histopathological evaluation. Data were entered and analyzed by using one-way ANOVA of SPSS version 25.

Identifiers

PMID35342648
PMCPMC8947931
OpenAlexW4220690155

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.